Last reviewed · How we verify

NCT01650870

A Single Center, Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Split-Dose Regimen of Crystalline Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults

Completed Phase 2 Last updated 7 August 2014
What this trial tests

Phase 2 trial testing Crystalline Lactulose in Colonoscopy in 40 participants. Completed in 1 September 2012.

Timeline
1 July 2012
Primary endpoint
1 September 2012
1 September 2012

Quick facts

Lead sponsorBenaroya Research Institute
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 July 2012
Primary completion1 September 2012
Estimated completion1 September 2012
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Benaroya Research Institute

Who can join

18 and older, any sex, with Colonoscopy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine the efficacy of a split-dose regimen of crystalline lactulose for cleansing of the colon as a preparation for colonoscopy, as assessed by the physician's determination of the cleanliness of the colon using the Boston Bowel Prep Scale (BBPS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

Other Benaroya Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01650870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing